Topic: How To Invest

Pat: What do you think of Abbott Laboratories as an investment?

Article Excerpt

Abbott Laboratories, $53.89, symbol ABT on New York (Shares outstanding: 1.6 billion; Market cap: $83.6 billion), makes and sells health-care products. Abbott has four segments: i) Pharmaceuticals, which contributes 58% of Abbott’s total sales, makes drugs for treating high cholesterol, rheumatoid arthritis, hypothyroidism, obesity, HIV, epilepsy, migraines, prostate cancer and anemia. ii) Diagnostic Products (11% of sales) includes chemistry systems, screening and diagnostic tests for cancer, therapeutic drug monitoring, fertility, physiological diseases and infectious diseases, such as hepatitis and HIV. It also includes hematology (blood testing) systems. iii) Nutritional Products (17% of sales) offers nutritional products through its own distribution centres to retailers, wholesalers, health-care facilities and government agencies. iv) Vascular Products (14% of sales) provides coronary, endovascular and vessel-closure devices for treating heart diseases. It also offers blood glucose monitoring meters, test strips, data-management software and accessories for people with diabetes. In January 2009, Abbott paid $2.8 billion in cash to acquire California-based Advanced Medical Optics, a leading eye-surgery…